U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
159001159001Investigation of Macular Pigment Augmentation on Dark AdaptationTerminatedNo Results AvailableAging|Age-Related Macular DegenerationDietary Supplement: ZeaVision EyePromise Restore|Dietary Supplement: Multivitaminhttps://ClinicalTrials.gov/show/NCT00478439
159002159002Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerActive, not recruitingNo Results AvailableEndometrial Adenocarcinoma|Endometrial Serous Adenocarcinoma|Recurrent Uterine Corpus Carcinoma|Recurrent Uterine Corpus Sarcoma|Stage IVA Uterine Corpus Cancer|Stage IVA Uterine Sarcoma|Stage IVB Uterine Corpus Cancer|Stage IVB Uterine Sarcoma|Uterine CaDrug: Sunitinib Malatehttps://ClinicalTrials.gov/show/NCT00478426
159003159003Awareness of Deficit After Combat-related Brain InjuryRecruitingNo Results AvailableTraumatic Brain Injury|Veteranshttps://ClinicalTrials.gov/show/NCT00478400
159004159004Ovarian Cancer and Immune Response to Flu VaccineRecruitingNo Results AvailableOvarian CancerBiological: The current season's trivalent killed influenza vaccinehttps://ClinicalTrials.gov/show/NCT00478387
159005159005Sorafenib With TACE to Treat Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular CarcinomaDrug: Sorafenib|Procedure: Transarterial chemoembolisation with doxorubicinhttps://ClinicalTrials.gov/show/NCT00478374
159006159006Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNo Results AvailableDistal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Regional Transitional CDrug: Gemcitabine hydrochloride|Drug: Paclitaxel|Drug: Doxorubicin hydrochloride|Drug: Pegfilgrastimhttps://ClinicalTrials.gov/show/NCT00478361
159007159007Should Prosthetic Repair of Incisional Abdominal Hernias be Drain or Not?RecruitingNo Results AvailablePostoperative Complications|HerniaProcedure: Prosthetic repair of abdominal incisional herniahttps://ClinicalTrials.gov/show/NCT00478348
159008159008Pharmacologic Treatment of Congenital Nephrogenic Diabetes InsipidusCompletedNo Results AvailableNephrogenic Diabetes InsipidusDrug: sildenafil|Drug: calcitonin|Drug: hydrochlorothiazide/amiloride|Drug: indomethacin|Drug: Placebo for sildenafil|Drug: placebo for calcitoninhttps://ClinicalTrials.gov/show/NCT00478335
159009159009Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic SubjectsCompletedNo Results AvailableDiabetes Mellitus Type 2;|ObesityDrug: Placebo|Drug: INCB013739https://ClinicalTrials.gov/show/NCT00478322
159010159010Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy ParticipantsActive, not recruitingNo Results AvailableColorectal Cancer|Healthy, no Evidence of DiseaseOther: counseling intervention|Other: educational interventionhttps://ClinicalTrials.gov/show/NCT00478309
159011159011Pulmonary Hypertension in Trisomy 21 PatientsCompletedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00478296
159012159012Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast CancerCompletedNo Results AvailableBreast CancerOther: survey administrationhttps://ClinicalTrials.gov/show/NCT00478283
159013159013A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.TerminatedNo Results AvailablePain;|Bone Neoplasms;|Neoplasm MetastasisDrug: ibandronate [Bondronat]https://ClinicalTrials.gov/show/NCT00478270
159014159014Effect of Increased Light Exposure on Fatigue in Breast CancerCompletedNo Results AvailableBreast CancerDevice: light box ( Litebook)|Device: light box ( Litebook)https://ClinicalTrials.gov/show/NCT00478257
159015159015Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis BullosaTerminatedHas ResultsEpidermolysis BullosaDrug: busulfan|Drug: cyclophosphamide|Drug: fludarabine phosphate|Procedure: hematopoietic bone marrow transplantationhttps://ClinicalTrials.gov/show/NCT00478244
159016159016Multicenter, Safety Study Of MaravirocCompletedHas ResultsAcquired Immunodeficiency Syndrome|HIV InfectionDrug: Maravirochttps://ClinicalTrials.gov/show/NCT00478231
159017159017Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedHas ResultsMultiple Myeloma and Plasma Cell NeoplasmDrug: cyclophosphamide|Drug: dexamethasone|Drug: lenalidomidehttps://ClinicalTrials.gov/show/NCT00478218
159018159018Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's DiseaseCompletedHas ResultsAlzheimer's DiseaseDrug: Aricept (donepezil SR 23 mg)|Drug: Aricept (donepezil IR 10 mg)https://ClinicalTrials.gov/show/NCT00478205
159019159019Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedHas ResultsHyponatremiaDrug: Conivaptan|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00478192
159020159020Study of a Bupivacaine Patch (Eladurâ„¢) to Treat Post- Herpetic NeuralgiaCompletedNo Results AvailablePostherpetic Neuralgia|PainDrug: Transdermal/Patch (Bupivacaine TTS [Eladurâ„¢])https://ClinicalTrials.gov/show/NCT00478179
159021159021Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's DiseaseCompletedNo Results AvailableMagnetic Resonance Imaging|Alzheimer's Disease|Dementia|Adult Children|Riskhttps://ClinicalTrials.gov/show/NCT00478166
159022159022Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by SurgeryCompletedHas ResultsAdenocarcinoma of the Extrahepatic Bile Duct|Adenocarcinoma of the Gallbladder|Malignant Neoplasm|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder CancerBiological: trastuzumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00478140
159023159023Hepatocyte Growth Factor and Cardiovascular Autonomic FunctionCompletedNo Results AvailableType-2 Diabeteshttps://ClinicalTrials.gov/show/NCT00478127
159024159024Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)CompletedNo Results AvailableRenal Cell CarcinomaDrug: sorafenibhttps://ClinicalTrials.gov/show/NCT00478114
159025159025Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer PainCompletedNo Results AvailableAdvanced Solid CancersDrug: oxycodone fentanylhttps://ClinicalTrials.gov/show/NCT00478101
159026159026Evaluating The Safety and Effectiveness of The NeoDiscâ„¢ Versus ACDF in Subjects With Single-Level Cervical Disc DiseaseCompletedNo Results AvailableCervical Disc Degenerative DisorderDevice: NeoDisc|Device: Instrumented Anterior Cervical Discectomy and Fusion (ACDF)https://ClinicalTrials.gov/show/NCT00478088
159027159027Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDrug: bortezomib|Other: immunologic technique|Radiation: samarium Sm 153 lexidronam pentasodiumhttps://ClinicalTrials.gov/show/NCT00478075
159028159028Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's LymphomaTerminatedNo Results AvailableLymphomaBiological: Hodgkin's antigens-GM-CSF-expressing cell vaccine|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00478062
159029159029Iressa as Second Line Therapy in Advanced NSCLC-AsiaCompletedNo Results AvailableNSCLCDrug: Gefitinib|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00478049
159030159030Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and CellsCompletedNo Results AvailableOpen Angle GlaucomaDrug: Acular LS|Drug: Pred Forte|Other: Refresh Tearshttps://ClinicalTrials.gov/show/NCT00478036

* Görseller ve İçerik tekif hakkına sahip olabilir